Thomas B. Smith

CIK: 0001748462

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (20.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (40.0%)

Compensation grants

Other (G, F, J, C, D, …)4 (40.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

COLL

COLLEGIUM PHARMACEUTICAL, INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (10 total)

COLL
COLLEGIUM PHARMACEUTICAL, INC
Feb 10, 2026
Tax Payment(F)
Direct
11.5K shares at avg. $46.75$539K
COLL
COLLEGIUM PHARMACEUTICAL, INC
Feb 10, 2026
Award(A)
Direct
14.3K shares-
COLL
COLLEGIUM PHARMACEUTICAL, INC
Feb 10, 2026
Award(A)
Direct
22.8K shares-
COLL
COLLEGIUM PHARMACEUTICAL, INC
Feb 10, 2026
Tax Payment(F)
Direct
5.9K shares at avg. $46.75$276K
COLL
COLLEGIUM PHARMACEUTICAL, INC
Aug 29, 2025
Sale(S)
Direct
17.5K shares at avg. $38.42$672K
COLL
COLLEGIUM PHARMACEUTICAL, INC
Feb 10, 2025
Tax Payment(F)
Direct
4.4K shares at avg. $30.52$134K
COLL
COLLEGIUM PHARMACEUTICAL, INC
Feb 10, 2025
Award(A)
Direct
33.8K shares-
COLL
COLLEGIUM PHARMACEUTICAL, INC
Feb 10, 2025
Award(A)
Direct
5.3K shares-
COLL
COLLEGIUM PHARMACEUTICAL, INC
Feb 10, 2025
Tax Payment(F)
Direct
1.5K shares at avg. $30.52$46K
COLL
COLLEGIUM PHARMACEUTICAL, INC
Sep 13, 2024
Sale(S)
Direct
9.6K shares at avg. $36.62$351K

		Type	Shares	Price		Ownership
Feb 10, 2026	COLL COLLEGIUM PHARMACEUTICAL, INC	Tax Payment(F)	11,538	$46.75	$539,402	Direct
Feb 10, 2026	COLL COLLEGIUM PHARMACEUTICAL, INC	Award(A)	14,268	-	$0	Direct
Feb 10, 2026	COLL COLLEGIUM PHARMACEUTICAL, INC	Award(A)	22,774	-	$0	Direct
Feb 10, 2026	COLL COLLEGIUM PHARMACEUTICAL, INC	Tax Payment(F)	5,897	$46.75	$275,685	Direct
Aug 29, 2025	COLL COLLEGIUM PHARMACEUTICAL, INC	Sale(S)	17,478	$38.42	$671,576	Direct
Feb 10, 2025	COLL COLLEGIUM PHARMACEUTICAL, INC	Tax Payment(F)	4,399	$30.52	$134,257	Direct
Feb 10, 2025	COLL COLLEGIUM PHARMACEUTICAL, INC	Award(A)	33,762	-	-	Direct
Feb 10, 2025	COLL COLLEGIUM PHARMACEUTICAL, INC	Award(A)	5,313	-	-	Direct
Feb 10, 2025	COLL COLLEGIUM PHARMACEUTICAL, INC	Tax Payment(F)	1,498	$30.52	$45,719	Direct
Sep 13, 2024	COLL COLLEGIUM PHARMACEUTICAL, INC	Sale(S)	9,593	$36.62	$351,320	Direct

1-10 of 10 transactions

About Smith Thomas B

Smith Thomas B (SEC CIK 0001748462) files insider reports with the SEC as EVP and Chief Medical Officer of COLLEGIUM PHARMACEUTICAL, INC (COLL).

Signal8 holds 4 ownership filings by Smith Thomas B, all Form 4s, filed between Sep 17, 2024 and Feb 12, 2026. Those filings report 10 transactions, from Sep 13, 2024 to Feb 10, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Smith Thomas B's filings is in STOUGHTON, MA.

Recent filings by Smith Thomas B

Feb 10, 2026: Tax withholding of COLL shares (Form 4, code F).
Feb 10, 2026: Grants or awards of COLL shares (2 lines, Form 4, code A).
Feb 10, 2026: Tax withholding of COLL shares (Form 4, code F).
Aug 29, 2025: Open-market sale of COLL shares (Form 4, code S).
Feb 10, 2025: Tax withholding of COLL shares (Form 4, code F).

Other insiders filing for COLLEGIUM PHARMACEUTICAL, INC (COLL)

SANTINI GINO, Director
Freund John Gordon, Director
Lurker Nancy, Director
Paya Carlos V, Director
Glancy Donovan Michael, Director
BOHLIN GAREN G, Director

How to read Form 4 transaction codes